Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
SOLUM and Alltrack Medical Partner on Smart Healthcare Management
SOLUM, a global leader in retail solutions, has partnered with Alltrack Medical, a Dutch company at the forefront of digital healthcare innovation, to introduce advanced connected solutions that enhance efficiency and sustainability in healthcare operations. The collaboration combines SOLUM’s proven technology with Alltrack Medical’s expertise in healthcare logistics to create a more connected, streamlined, and data-driven ecosystem for hospitals, clinics, and other care facilities.
H.I.G. Realty and Barts NHS Launch First Life Sciences Project
H.I.G. Capital, a leading global alternative investment firm managing $74 billion in assets, has announced a strategic partnership with Barts Health NHS Trust to develop the first applied healthcare innovation building within the newly established Barts Life Sciences Cluster on Cavell Street in Whitechapel, London. The project brings together one of the largest NHS Trusts in the UK, a global investment firm, and a specialist science and technology developer to create new models of collaboration between clinicians, researchers, and industry partners. Spanning 170,000 square feet, the Cavell Street development is positioned as a landmark within the Cluster, signaling a new phase of health innovation in East London focused on merging clinical expertise with commercial capability.
EQT Life Sciences co-leads €51M Series B for Exciva Alz Phase 2
EQT Life Sciences has announced that its LSP Dementia Fund has joined as a co-lead investor in a EUR 51 million Series B financing round for Exciva, a clinical-stage biopharmaceutical company focused on developing new treatments for behavioral symptoms linked to Alzheimer’s disease. The funding marks a significant step forward for the company as it prepares to advance its lead therapy into mid-stage clinical development, addressing an area of high unmet medical need within neurodegenerative care.
CareXM Introduces AI Voice Agent to Improve Patient Access and Preserve Clinician Capacity
CareXM has announced the launch of an AI Voice Agent within its non-clinical answering platform, designed to help healthcare providers manage growing call volumes without increasing operational pressure. The new system replaces traditional IVR menus with natural conversational dialogue that engages patients immediately, captures multiple requests in a single call, sequences follow-ups for care teams, and escalates urgent clinical needs to providers in real time.
LifeArc and GAP Scientists Test Finger Prick Alzheimer’s Test
A major international research initiative is exploring whether a simple finger-prick blood test could be used to diagnose Alzheimer’s disease before symptoms appear. The trial focuses on three specific proteins in the blood that are linked to Alzheimer’s and will compare these results with the current gold standard diagnostic methods, which rely on costly brain scans and invasive procedures that are not easily accessible to many patients. The finger-prick method uses a plasma separation card, making it inexpensive, easy to handle, and suitable for storage and shipment at room temperature without the need for refrigeration. If successful, this approach could provide a scalable, accessible, and cost-effective way to screen for Alzheimer’s disease, enabling earlier intervention and offering a better chance to slow disease progression or delay the onset of symptoms.
To share your insights, please write to us at sudipto@intentamplify.com
